ecrin-mdr-crcClinical2004Colon CancerColorectal NeoplasmsRectal CancerColon CancerColorectal NeoplasmsRectal CancerInterventionalhttps://newmdr.ecrin.org/Study/201215112Motesanib diphosphatePanitumumabAMG 706ECRIN MDRCompletedfalseSafety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal CancerThe purpose of this study is to characterize the safety and tolerability of AMG 706 plus panitumumab when administered with either FOLFIRI or FOLFOX4 chemotherapy regimens. This is a Phase 1b clinical study.2004-12-152012151NCT00101894